Association For Molecular Pathology et al v. United States Patent and Trademark Office et al

Filing 198

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by BayBio, The Coalition for 21st Century Medicine, Target Discovery, Inc., XDx, Inc.. (Attachments: # 1 Certificate of Service)(Huttenlocher, Michael)

Download PDF
Association For Molecular Pathology et al v. United States Patent and Trademark Office et al Doc. 198 IN THE UNITED STATES DISTRICT COURT IN AND FOR THE SOUTHERN DISTRICT OF NEW YORK ASSOCIATION FOR MOLECULAR PATHOLOGY, et al., Plaintiffs, v. UNITED STATES PATENT AND TRADEMARK OFFICE, et al., Defendants. CASE NO. 09-CV-4515 (RWS) ECF RULE 7.1 CORPORATE DISCLOSURE STATEMENT Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, nonparties and proposed Amici Curiae BayBio, The Coalition for 21st Century Medicine, Target Discovery, Inc. and XDx, Inc. state that none of these entities have a parent corporation and that no publicly held corporation owns 10% or more stock in these proposed Amici Curiae. DATED: January 8, 2010 Respectfully Submitted, By: /s/ Michael R. Huttenlocher Michael R. Huttenlocher Obiamaka P. Madubuko MCDERMOTT WILL & EMERY LLP 340 Madison Avenue New York, NY 10173-1922 Telephone: (212) 547-5400 Facsimile: (212) 547-5444 omadubuko@mwe.com Of Counsel: William G. Gaede, III Andrew A. Kumamoto MCDERMOTT WILL & EMERY LLP 275 Middlefield Road, Suite 100 Menlo Park, CA 94025 wgaede@mwe.com akumamoto@mwe.com Counsel of Record for Amici Curiae -1MPK 160247-2.009900.0023 Dockets.Justia.com